Home > Insider Trading > Nexvet Biopharma Plc > Profile

Nexvet Biopharma Plc (NVET)

Market is closed

Related Insiders

Bernard John Payne, Director, 2017-08-03
S Joseph Mccracken, Director, 2017-08-03
T. Damian Lismore, Chief Financial Officer, 2017-08-03

Bernard John Payne, Director, 2017-08-03
S Joseph Mccracken, Director, 2017-08-03
T. Damian Lismore, Chief Financial Officer, 2017-08-03
G Cormac Kilty, Director, 2017-08-03
Jurgen Horn, Chief Product Development Ofcr, 2017-08-03
Mark Heffernan, Chief Executive Officer, 2017-08-03
Ashraf Hanna, Director, 2017-08-03
W George Gunn, Director, 2017-08-03
T Geraldine Farrell, Vp Operations, General Counsel, 2017-08-03
Nigel Christopher Brown, Director, 2017-08-03
A Rajiv Patel, Director, 2017-08-02
C Mark Wehrly, Large Shareholder, Other, 2017-08-02
William Seybold, Large Shareholder, Other, 2017-08-02
K Ravi Paidipaty, Large Shareholder, Other, 2017-08-02
T David Kim, Large Shareholder, Other, 2017-08-02
R. John Warren, Large Shareholder, Other, 2017-08-02
G Michael Linn, Large Shareholder, Other, 2017-08-02
Jr. G. Thomas Roberts, Large Shareholder, Other, 2017-08-02
M J Andrew Spokes, Large Shareholder, Other, 2017-08-02
B Richard Fried, Large Shareholder, Other, 2017-08-02
R Monica Landry, Large Shareholder, Other, 2017-08-02
D Philip Dreyfuss, Large Shareholder, Other, 2017-08-02
Farallon Capital Management Llc, Large Shareholder, Other, 2017-08-02
C/Ca L L Partners Farallon, Large Shareholder, Other, 2017-08-02
B. Michael Fisch, Large Shareholder, Other, 2017-08-02
Akubra Investors, Llc, Large Shareholder, Other, 2017-08-02
Bushranger Funding, Llc, Large Shareholder, Other, 2017-08-02
Ute Holdings, Llc, Large Shareholder, Other, 2017-08-02
Ngp, L.l.c., Large Shareholder, Other, 2017-08-02
Farallon Aa G.p., L.l.c., Large Shareholder, Other, 2017-08-02
Farallon Partners Gp Vi, L.l.c., Large Shareholder, Other, 2017-08-02
J. Daniel Hirsch, Large Shareholder, Other, 2017-01-11
David Gearing, Chief Scientific Officer, 2016-11-09
Colin Giles, Vp Clinical&Regulatory Affairs, 2015-09-08
Graeme Wald, Director, 2015-07-16
Phillip Gross, Large Shareholder, 2015-02-10
Robert Atchinson, Large Shareholder, 2015-02-10
Adage Capital Advisors, L.l.c., Large Shareholder, 2015-02-10
Adage Capital Partners Gp Llc, Large Shareholder, 2015-02-10
Adage Capital Partners, L.p., Large Shareholder, 2015-02-10
Ii Fund Healthcare Pacific Asia Atf Ltd Management Funds One, Large Shareholder, 2015-02-10

Insider Trading: Purchases See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Gearing Officer	$3.35	9,000	$30,150.00	125,903	2016-03-04	Filing
Gearing Officer	$3.26	2,113	$6,888.38	116,903	2016-03-03	Filing
Hanna Director	$3.20	1,500	$4,800.00	1,500	2016-03-02	Filing
Gearing Officer	$3.34	12,126	$40,500.84	114,790	2016-02-26	Filing
Gearing Officer	$3.30	19,000	$62,700.00	102,664	2016-02-25	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Farrell Officer	$3.27	132	$431.65	0	2016-03-03	Filing

News See All

Click here to See All News

Nexvet Biopharma Plc (NVET)

Related Insiders

13D Filing: Farallon Capital and Nexvet Biopharma PLC (NVET)

Here's What You Need To Know About The Financial Markets Today

Nexvet Biopharma Plc (NVET) Soars After M&A With Zoetis; Records New 52-week High

Bill & Melinda Gates Foundation Trust's Latest Bet on China & Two Other Latest Hedge Fund Moves

Hedge Funds Expect Big Things From 1 Of These 2 Sliding Biotechs

Nexvet Biopharma plc (NVET), Allergan, Inc. (AGN), DIRECTV (DTV) : Farallon Capital's New Activist Position and Top Picks